EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neocryptomerin targets NAE1 to induce DNA re-replication and DNA damage by inhibiting neddylation-mediated CDT1 degradation in gastric cancer

Peng Tan, Dongjun Fu, Fei Wang, Zhuguo Wang, Huiming Huang, Xuejiao Wei, Xinyu Qiu, Yufeng Gao, Ruoxin Zhang, Xiaoxue Wang, Wanying Xie, Zhongdong Hu

Pharmacological Research · 2026-07 · 229 · 108255

DOI: 10.1016/j.phrs.2026.108255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2026-07. Verfasst von Peng Tan und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China; Beijing Research Institute of Chinese Medicine, Beij…. Hauptthemen laut MEDLINE: Stomach Neoplasms, DNA Damage, DNA Replication, Biflavonoids. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Beijing University of Chinese Medicine, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) remains a globally prevalent malignancy, necessitating the development of effective therapeutics. Natural products are an important source for the development of anti-tumor drugs. Neocryptomerin (Neo) is a natural biflavonoid derived from Selaginella Herba, yet its efficacy and mechanism against GC were unexplored. This study demonstrated that Neo significantly reduced the proliferation and triggered apoptosis of GC cells. Neo induced DNA re-replication, S-phase arrest, and DNA damage in these cells. Additionally, Neo substantially suppressed tumor growth in a HGC-27 xenograft mouse model, achieving a 68.39% tumor inhibition rate. Moreover, Neo suppressed cell proliferation and promoted apoptosis in tumor tissues from mice. Mechanistically, upregulation of CDT1 was involved in Neo-induced DNA re-replication, S-phase arrest, and DNA damage in GC cells. Importantly, Neo suppressed neddylation by targeting NAE1 in GC cells. Altering NAE1 expression notably decreased the sensitivity of GC cells to Neo treatment. Moreover, NAE1 was involved in Neo's regulation of neddylation and CDT1. In addition, NAE1 had oncogenic potential in GC. Collectively, Neo exhibited significant anti-GC activity through targeting NAE1 to induce DNA re-replication, S-phase arrest, and DNA damage by inhibiting neddylation-mediated CDT1 degradation. Therefore, as a novel natural neddylation pathway inhibitor, Neo is a promising candidate drug for GC treatment. NAE1 could serve as a potential therapeutic target for GC. This work offers a new strategy for the development of novel neddylation pathway inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsDNA DamageDNA ReplicationBiflavonoidsCell Cycle ProteinsNEDD8 ProteinHumansAnimalsCell Line, TumorCell ProliferationMice, NudeApoptosisProteolysisMice, Inbred BALB CMice

Stichwörter der Autor:innen

CDT1DNA re-replicationNAE1Neocryptomeringastric cancerneddylation

Substanzen

CDT1 protein, humanBiflavonoidsCell Cycle ProteinsNEDD8 Protein

Autor:innen und Institutionen

  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, China; Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China. Electronic address: zdhu@bucm.edu.cn.

Förderung

  • Fundamental Research Funds for the Central Universities
  • Beijing University of Chinese Medicine
  • Beijing Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Tan, P., Fu, D., Wang, F., Wang, Z., Huang, H., Wei, X., Qiu, X., Gao, Y., Zhang, R., Wang, X., Xie, W., & Hu, Z. (2026). Neocryptomerin targets NAE1 to induce DNA re-replication and DNA damage by inhibiting neddylation-mediated CDT1 degradation in gastric cancer. Pharmacological Research, 229, 108255. https://doi.org/10.1016/j.phrs.2026.108255

Vancouver

Tan P, Fu D, Wang F, Wang Z, Huang H, Wei X, et al. Neocryptomerin targets NAE1 to induce DNA re-replication and DNA damage by inhibiting neddylation-mediated CDT1 degradation in gastric cancer. Pharmacological Research. 2026;229:108255. doi:10.1016/j.phrs.2026.108255

BibTeX
@article{Tan2026,
  author = {Tan, Peng and Fu, Dongjun and Wang, Fei and Wang, Zhuguo and Huang, Huiming and Wei, Xuejiao and Qiu, Xinyu and Gao, Yufeng and Zhang, Ruoxin and Wang, Xiaoxue and Xie, Wanying and Hu, Zhongdong},
  title = {Neocryptomerin targets NAE1 to induce DNA re-replication and DNA damage by inhibiting neddylation-mediated CDT1 degradation in gastric cancer},
  journal = {Pharmacological Research},
  year = {2026},
  volume = {229},
  pages = {108255},
  doi = {10.1016/j.phrs.2026.108255}
}
Kostenlos starten →